| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 95 |
| 1 | ASPIRIN 325 MG | 93 |
| 2 | ASPIRIN 81 MG | 93 |
| 3 | PREDNISOLONE | 66 |
| 4 | PREDNISOLONE ORAL | 66 |
| 5 | PREDNISOLONE ORAL SOLUTION | 66 |
| 6 | NITROGLYCERIN | 53 |
| 7 | CAPECITABINE | 50 |
| 8 | FLUOROURACIL | 50 |
| 9 | FLUOROURACIL CREAM, 0.5% | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETYLCHOLINE CHLORIDE | 6 | 0.0612 |
| 1 | DROSPIRENONE AND ESTETROL | 3 | 0.0101 |
| 2 | CARTEOLOL HYDROCHLORIDE | 3 | 0.0090 |
| 3 | ANAGRELIDE HYDROCHLORIDE | 10 | 0.0085 |
| 4 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 5 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| 6 | DIHYDROERGOTAMINE MESYLATE | 5 | 0.0037 |
| 7 | DEXMEDETOMIDINE HYDROCHLORIDE | 11 | 0.0037 |
| 8 | CALCIFEDIOL | 9 | 0.0035 |
| 9 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 139 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 124 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 100 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 95 |
| 4 | Nitrate Vasodilator [EPC] | 90 |
| 5 | Platinum-based Drug [EPC] | 72 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 58 |
| 7 | beta-Adrenergic Blocker [EPC] | 55 |
| 8 | Proton Pump Inhibitor [EPC] | 53 |
| 9 | Benzodiazepine [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 12 | 0.0021 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 26 | 0.0010 |
| 4 | Nitrate Vasodilator [EPC] | 90 | 0.0010 |
| 5 | General Anesthetic [EPC] | 33 | 0.0008 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 7 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 8 | Anticholinergic [EPC] | 8 | 0.0005 |
| 9 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |